Seraph Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.10 M
as on 13-12-2024
- Satisfied Charges ₹ 1.00 M
as on 13-12-2024
- Revenue 65.57%
(FY 2017)
- Profit -55.38%
(FY 2017)
- Ebitda -28.37%
(FY 2017)
- Net Worth 6.04%
(FY 2017)
- Total Assets -12.26%
(FY 2017)
About Seraph Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.10 M. The company has closed loans amounting to ₹1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sunita Yadav and Amit Yadav serve as directors at the Company.
- CIN/LLPIN
U74120MH2013PTC239992
- Company No.
239992
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jan 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Seraph Life Sciences Private Limited offer?
Seraph Life Sciences Private Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Skin Ointment, Hand Sanitizers & Personal Hygiene, Bath Tools, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Bath Soaps.
Who are the key members and board of directors at Seraph Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunita Yadav  | Director | 26-Dec-2016 | Current |
| Amit Yadav | Director | 28-Jan-2013 | Current |
Financial Performance of Seraph Life Sciences.
Seraph Life Sciences Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 65.57% increase. The company also saw a substantial fall in profitability, with a 55.38% decrease in profit. The company's net worth moved up by a moderate rise of 6.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Seraph Life Sciences?
In 2017, Seraph Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Admak Pharmaceuticals Private LimitedActive 9 years 5 monthsSunita Yadav and Amit Yadav are mutual person
- Adsra Logistics Private LimitedActive 6 years 11 months
Sunita Yadav and Amit Yadav are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 May 2019 | ₹5.10 M | Open |
Others Creation Date: 17 Nov 2015 | ₹1.00 M | Satisfied |
How Many Employees Work at Seraph Life Sciences?
Seraph Life Sciences has a workforce of 16 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Seraph Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seraph Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
